US watchdog says AstraZeneca may have used outdated info in vaccine trial
Published
The US watchdog urged AstraZeneca to "ensure the most accurate, up-to-date efficacy data be made public as quickly as possible."
Full ArticlePublished
The US watchdog urged AstraZeneca to "ensure the most accurate, up-to-date efficacy data be made public as quickly as possible."
Full ArticleAstraZeneca will publish up-to-date results from its major U.S. COVID-19 vaccine trial within 48 hours after health officials..
AstraZeneca should urgently ensure the most accurate, up-to-date vaccine efficacy data was made public, the NIAID said.